The role of quantitative policy analysis in HIV prevention technology transfer.

Por Holtgrave, David R.
Publicado em 2004

Costs and Consequences of the US Centers for Disease Control and Prevention's Recommendations for Opt-Out HIV Testing

Por Holtgrave, David R
Publicado em 2007

When “Heightened” Means “Lessened”: The Case of HIV Prevention Resources in the United States

Por Holtgrave, David R.
Publicado em 2007

MEASURING THE VALUE OF PUBLIC HEALTH SYSTEMS

Por Holtgrave, David R.
Publicado em 2009

Is the Elimination of HIV Infection Within Reach in the United States? Lessons from an Epidemiologic Transmission Model

Por Holtgrave, David R.
Publicado em 2010

Holtgrave Responds

Por Holtgrave, David R.
Publicado em 2010

Widespread and frequent testing is essential to controlling COVID-19 in the United States

Por Rosenberg, Eli S, Holtgrave, David R
Publicado no Clin Infect Dis (2020)

Challenges in defining an optimal approach to formula-based allocations of public health funds in the United States

Por Buehler, James W, Holtgrave, David R
Publicado em 2007

Can Increasing Awareness of HIV Seropositivity Reduce Infections by 50% in the United States?

Por Holtgrave, David R., Pinkerton, Steven D.
Publicado em 2007

Additional Indicators to Measure New HIV Diagnoses: A Response to Chow et al

Por Bonacci, Robert A., Holtgrave, David R.
Publicado no J Acquir Immune Defic Syndr (2016)

Responding to Pandemics: What We’ve Learned from HIV/AIDS

Por Valdiserri, Ronald O., Holtgrave, David R.
Publicado no AIDS Behav (2020)

Clarifying the record on hydroxychloroquine for the treatment of patients hospitalized with COVID-19

Por Rosenberg, Eli S., Holtgrave, David R., Udo, Tomoko
Publicado no Int J Infect Dis (2020)

HIV Transmission Rates in the United States, 2006-2008

Por Holtgrave, David R, Hall, H. Irene, Prejean, Joseph
Publicado em 2012

Effect of Medicaid Expansions on HIV Diagnoses and Pre-Exposure Prophylaxis Use

Por Farkhad, Bita Fayaz, Holtgrave, David R., Albarracín, Dolores
Publicado no Am J Prev Med (2021)

Valdiserri and Colleagues Respond

Por Valdiserri, Ronald O., Holtgrave, David R., Brackbill, Robert M.
Publicado em 1994

The Magnitude of Key HIV Prevention Challenges in the United States: Implications for a New National HIV Prevention Plan

Por Holtgrave, David R., McGuire, Jean Flatley, Milan, Jesse
Publicado em 2007

Barrier Methods for the Prevention of Infectious Diseases: Decades of Condom Research can Inform the Promotion of Face Mask Use

Por Valdiserri, Ronald O., Holtgrave, David R., Kalichman, Seth C.
Publicado no AIDS Behav (2020)

Determining the Cost-Savings Threshold for HIV Adherence Intervention Studies for Persons with Serious Mental Illness and HIV

Por Wu, Evan S., Rothbard, Aileen, Holtgrave, David R., Blank, Michael B.
Publicado no Community Ment Health J (2014)

2015–2020 National HIV/AIDS Strategy Goals for HIV Linkage and Retention in Care: Recommendations From Program Implementers

Por Jain, Kriti M., Maulsby, Cathy, Kinsky, Suzanne, Charles, Vignetta, Holtgrave, David R.
Publicado no Am J Public Health (2016)

Assessing racial and ethnic disparities using a COVID-19 outcomes continuum for New York State

Por Holtgrave, David R., Barranco, Meredith A., Tesoriero, James M., Blog, Debra S., Rosenberg, Eli S.
Publicado no Ann Epidemiol (2020)